ROSUVASTATIN Drug Patent Profile
✉ Email this page to a colleague
When do Rosuvastatin patents expire, and what generic alternatives are available?
Rosuvastatin is a drug marketed by Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Aurobindo Pharma Ltd, Biocon Pharma, Cadila Pharms Ltd, Changzhou Pharm, Chartwell Rx, Glenmark Speclt, Hetero Labs Ltd V, Inventia, Lupin, MSN, Renata, Sandoz, Sciegen Pharms Inc, Shandong, Strides Pharma, Sun Pharm, Sunshine, Teva Pharms Usa, Torrent, Umedica, Watson Labs Inc, Zhejiang Jingxin, and Zhejiang Yongtai. and is included in twenty-seven NDAs.
The generic ingredient in ROSUVASTATIN is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rosuvastatin
A generic version of ROSUVASTATIN was approved as rosuvastatin calcium by WATSON LABS INC on April 29th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROSUVASTATIN?
- What are the global sales for ROSUVASTATIN?
- What is Average Wholesale Price for ROSUVASTATIN?
Summary for ROSUVASTATIN
US Patents: | 0 |
Applicants: | 27 |
NDAs: | 27 |
Drug Prices: | Drug price information for ROSUVASTATIN |
Drug Sales Revenues: | Drug sales revenues for ROSUVASTATIN |
DailyMed Link: | ROSUVASTATIN at DailyMed |
US Patents and Regulatory Information for ROSUVASTATIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shandong | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207375-004 | May 7, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Zhejiang Jingxin | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206513-001 | Mar 1, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hetero Labs Ltd V | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207616-001 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Changzhou Pharm | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 207408-004 | Oct 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |